Lymph node spread in esophageal cancer study
Part of Cancer, Digestive system clinical trials.
This study looks at how often cancer has spread to lymph nodes in people with esophageal squamous cell carcinoma. It may help doctors plan better treatment. You may be eligible if your cancer hasn't spread to other organs and you haven't had another cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of esophageal cancer called squamous cell carcinoma.
- Your cancer is at stage cT1 to cT4a and may or may not have spread to nearby lymph nodes, but not to distant organs.
- You have not had any other cancer in the past.
- Your cancer is not in the neck area of the esophagus.
- You are healthy enough to have surgery to remove the esophagus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how often a specific lymph node (106TBL) is involved in esophageal squamous cell carcinoma. It may help guide treatment decisions for people who have not had other cancers and whose tumor is in the chest (not the neck).
This study uses special scans (spectral CT, multimodal MRI, and FAPI PET-CT) before and after treatment to better detect if esophageal cancer has spread to lymph nodes. It aims to improve diagnosis by comparing scan images with tissue removed during surgery.
This study tracks patients with stage IV esophageal or gastroesophageal junction cancer that has spread to only a limited number of places (like the liver, lung, or a few lymph nodes). The goal is to understand how well treatments like surgery or radiation work after initial drug therapy.
This trial compares two ways of managing early-stage esophageal cancer after it has been removed through an endoscope: one group has lymph nodes removed (surgery), the other does not. It aims to find out if skipping lymph node removal is safe and effective.
This trial is testing a combination of chemotherapy and radiation (called total neoadjuvant therapy) before surgery for a type of esophageal cancer that has spread to lymph nodes. The goal is to see if this approach improves outcomes.
This research examines tissue samples from patients who had surgery to remove advanced esophageal cancer in the neck or chest area. The study aims to understand how the cancer invaded surrounding tissues, which may help doctors better treat similar patients in the future.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.